Are syntetic slings safe? Opinion: No

Ackerman, A. Lenore; Raz, Shlomo

doi:10.1590/s1677-5538.ibju.2016.04.03

Cited by 2 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our overall vaginal extrusion rate was 9.9% and the median time to onset of extrusion was 4.5 months. It is difficult to compare these results, since extrusion definition varies in literature, besides vaginal extrusion correlates with several variables such as characteristics of the mesh, follow-up extension, intrinsic patient factors and the surgical route of the sling (5,6). Furthermore, long-term extrusions may not be properly assessed by teleconsultations, especially those asymptomatic patients.…”

Section: Discussionmentioning

confidence: 99%

“…Midurethral synthetic slings (MUS) became the most commonly performed minimally--invasive procedure for treating female stress urinary incontinence (SUI) worldwide (1,2) and are regarded as the gold standard surgical treatment (3,4). There are different types and brands of commercial synthetic slings, each with their own characteristics, which can be related to dis-tinct complications (5)(6)(7).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Incontinence outcomes in women undergoing retropubic mid-urethral sling: a retrospective cohort study comparing Safyre™ and handmade sling

et al. 2022

View full text Add to dashboard Cite

Purpose: This study examined and compared efficacy, safety, satisfaction, and complications of the retropubic Safyre™ sling and a retropubic hand-made synthetic sling (HMS) in a short-, mid-and long-term follow-up. Methods: We retrospectively reviewed a prospectively maintained database of women who underwent Safyre™ or HMS between March 7 ths 2005 and December 27 ths , 2017. Patients had first assessment (7-10 days), second (40-45 days), and third (sixth month) postoperatively. Between September and December 2018, patients who completed at least one year of surgery, received a telephone call. Follow-up compared quartiles of follow-up time to determine complications (Clavien-Dindo), success rates (International Consultation on Incontinence Modular Questionnaire for Urinary Incontinence Short Form -ICIQ-UI SF), and patient satisfaction. Results: Three hundred fifty-one patients underwent surgery and 221 (63%) were evaluated after a median of 78.47 (± 38.69) months, 125 (55%) in the HMS, and 96 (45%) in the Safyre™ group. Higher intraoperative bladder injury was observed with Safyre™ (0% vs. 4.2%, p=0.034), and a tendency for urinary retention, requiring indwelling urinary catheter over 24 hours (2.4% vs. 8.3%, p=0.061). Both HMS (p<0.001) and Safyre™ (p<0.001) presented improvements on ICIQ-UI SF. There were no differences in satisfaction, subjective cure rates, ICIQ-UI SF, or complications between groups. Conclusions: Both HMS and Safyre™ have similar satisfaction and subjective cure rates, with marked ICIQ-UI SF score improvement. Higher rates of intraoperative bladder injury were seen in patients who received Safyre™ retropubic sling.

show abstract

Section: Discussionmentioning

confidence: 99%